107.66
price up icon2.52%   2.65
after-market アフターアワーズ: 107.66
loading
前日終値:
$105.01
開ける:
$106.75
24時間の取引高:
627.56K
Relative Volume:
0.83
時価総額:
$6.25B
収益:
$507.44M
当期純損益:
$-187.69M
株価収益率:
-32.91
EPS:
-3.271
ネットキャッシュフロー:
$-39.06M
1週間 パフォーマンス:
+2.31%
1か月 パフォーマンス:
-10.58%
6か月 パフォーマンス:
+32.02%
1年 パフォーマンス:
+9.39%
1日の値動き範囲:
Value
$104.78
$108.90
1週間の範囲:
Value
$102.12
$110.13
52週間の値動き範囲:
Value
$73.16
$130.23

Glaukos Corporation Stock (GKOS) Company Profile

Name
名前
Glaukos Corporation
Name
セクター
Healthcare (1114)
Name
電話
949-367-9600
Name
住所
1 GLAUKOS WAY, ALISO VIEJO, CA
Name
職員
1,094
Name
Twitter
@GlaukosCorp
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
GKOS's Discussions on Twitter

Compare GKOS vs ABT, SYK, MDT, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
GKOS icon
GKOS
Glaukos Corporation
107.66 6.10B 507.44M -187.69M -39.06M -3.271
ABT icon
ABT
Abbott Laboratories
102.67 177.03B 44.33B 6.50B 7.40B 3.717
SYK icon
SYK
Stryker Corp
328.59 124.89B 25.12B 3.25B 4.28B 8.3984
MDT icon
MDT
Medtronic Plc
86.65 110.08B 35.48B 4.64B 5.41B 3.582
BSX icon
BSX
Boston Scientific Corp
62.75 93.53B 20.08B 2.89B 3.66B 1.9391
EW icon
EW
Edwards Lifesciences Corp
80.08 45.84B 6.07B 1.06B 1.34B 1.8063

Glaukos Corporation Stock (GKOS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-27 アップグレード Wells Fargo Equal Weight → Overweight
2025-10-01 開始されました Goldman Buy
2025-05-01 ダウングレード Wells Fargo Overweight → Equal Weight
2025-02-19 アップグレード Mizuho Neutral → Outperform
2024-12-11 アップグレード Citigroup Neutral → Buy
2024-12-06 開始されました UBS Buy
2024-12-02 ダウングレード Morgan Stanley Equal-Weight → Underweight
2024-07-10 ダウングレード Citigroup Buy → Neutral
2024-05-06 アップグレード Jefferies Hold → Buy
2023-12-21 アップグレード JP Morgan Neutral → Overweight
2023-12-04 開始されました Morgan Stanley Equal-Weight
2023-11-28 開始されました Truist Buy
2023-11-08 アップグレード Wells Fargo Equal Weight → Overweight
2023-06-07 アップグレード Piper Sandler Neutral → Overweight
2022-12-22 開始されました Mizuho Neutral
2022-12-19 アップグレード JP Morgan Underweight → Neutral
2022-12-12 アップグレード Citigroup Neutral → Buy
2022-10-14 再開されました Stephens Overweight
2022-10-04 開始されました Needham Buy
2022-07-12 アップグレード Stifel Hold → Buy
2022-02-03 アップグレード William Blair Mkt Perform → Outperform
2022-01-19 アップグレード Wells Fargo Underweight → Equal Weight
2022-01-18 アップグレード BTIG Research Neutral → Buy
2021-11-03 アップグレード Stephens Equal-Weight → Overweight
2021-07-26 ダウングレード Stephens Overweight → Equal-Weight
2021-07-20 ダウングレード Wells Fargo Equal Weight → Underweight
2021-07-14 ダウングレード Oppenheimer Outperform → Perform
2021-07-14 ダウングレード William Blair Outperform → Mkt Perform
2021-04-08 アップグレード Oppenheimer Perform → Outperform
2021-01-29 ダウングレード Piper Sandler Overweight → Neutral
2020-12-16 アップグレード Citigroup Sell → Neutral
2020-12-09 開始されました Oppenheimer Perform
2020-11-17 アップグレード Wells Fargo Underweight → Equal Weight
2020-10-08 ダウングレード JP Morgan Neutral → Underweight
2020-06-15 開始されました Jefferies Hold
2020-03-05 開始されました Citigroup Sell
2020-02-28 ダウングレード JP Morgan Overweight → Neutral
2020-01-06 アップグレード Berenberg Hold → Buy
2019-12-12 ダウングレード Wells Fargo Outperform → Underperform
2019-09-30 ダウングレード BofA/Merrill Buy → Underperform
2019-03-08 開始されました BTIG Research Neutral
2018-08-30 開始されました Berenberg Hold
2018-08-29 アップグレード JP Morgan Neutral → Overweight
2018-08-03 繰り返されました Stifel Hold
2018-06-21 ダウングレード JP Morgan Overweight → Neutral
2018-04-13 ダウングレード Stifel Buy → Hold
2018-03-01 繰り返されました Cantor Fitzgerald Buy
2017-03-02 繰り返されました Cantor Fitzgerald Overweight
2017-01-06 アップグレード Stifel Hold → Buy
2016-10-27 開始されました Wells Fargo Outperform
すべてを表示

Glaukos Corporation (GKOS) 最新ニュース

pulisher
12:58 PM

Glaukos Corp. Experiences Evaluation Revision Amidst Mixed Market Signals and Volatility - Markets Mojo

12:58 PM
pulisher
Mar 30, 2026

Alex Thurman: ‘Phenomenal Year’ for Glaukos - Orange County Business Journal

Mar 30, 2026
pulisher
Mar 30, 2026

Price-Driven Insight from (GKOS) for Rule-Based Strategy - Stock Traders Daily

Mar 30, 2026
pulisher
Mar 28, 2026

Aug Chart Watch: Does Glaukos Corporation stock have upside surprise potential2026 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn

Mar 28, 2026
pulisher
Mar 28, 2026

Glaukos breaks ground on $80M R&D, manufacturing facility in Alabama - MSN

Mar 28, 2026
pulisher
Mar 28, 2026

Glaukos (NYSE:GKOS) CFO Sells $267,321.06 in Stock - MarketBeat

Mar 28, 2026
pulisher
Mar 27, 2026

Glaukos SVP Thurman sells $267k in GKOS stock - Investing.com

Mar 27, 2026
pulisher
Mar 27, 2026

Glaukos (NYSE: GKOS) president reports new stock and option grants - Stock Titan

Mar 27, 2026
pulisher
Mar 27, 2026

GLAUKOS (GKOS) CDO Tomas Navratil earns performance RSU stock awards - Stock Titan

Mar 27, 2026
pulisher
Mar 27, 2026

Glaukos Corporation (NYSE:GKOS): Is Breakeven Near? - 富途牛牛

Mar 27, 2026
pulisher
Mar 27, 2026

Glaukos launches Epioxa, boosts growth in corneal treatments - MSN

Mar 27, 2026
pulisher
Mar 27, 2026

Riverbridge Partners LLC Sells 34,475 Shares of Glaukos Corporation $GKOS - MarketBeat

Mar 27, 2026
pulisher
Mar 27, 2026

Assenagon Asset Management S.A. Has $20.59 Million Stock Position in Glaukos Corporation $GKOS - MarketBeat

Mar 27, 2026
pulisher
Mar 26, 2026

Glaukos (GKOS) Is Up 5.5% After Launching Incision-Free Epioxa Therapy For KeratoconusWhat's Changed - simplywall.st

Mar 26, 2026
pulisher
Mar 26, 2026

Vanguard realigns reporting; Vanguard subsidiaries to report GKOS holdings (GKOS) - Stock Titan

Mar 26, 2026
pulisher
Mar 25, 2026

Insider Selling: Glaukos (NYSE:GKOS) CFO Sells 1,521 Shares of Stock - MarketBeat

Mar 25, 2026
pulisher
Mar 25, 2026

Glaukos CFO Thurman sells $160k in shares By Investing.com - Investing.com Australia

Mar 25, 2026
pulisher
Mar 25, 2026

Glaukos CFO Thurman sells $160k in shares - Investing.com

Mar 25, 2026
pulisher
Mar 25, 2026

Glaukos (NYSE: GKOS) CDO has shares withheld to cover tax obligations - Stock Titan

Mar 25, 2026
pulisher
Mar 25, 2026

Glaukos (NYSE: GKOS) CFO sale and tax share withholdings detailed - Stock Titan

Mar 25, 2026
pulisher
Mar 25, 2026

Glaukos (NYSE: GKOS) insider plans sale of 2,511 vested shares - Stock Titan

Mar 25, 2026
pulisher
Mar 24, 2026

Glaukos (GKOS) affiliate files to sell 1,521 shares after vesting - Stock Titan

Mar 24, 2026
pulisher
Mar 23, 2026

Glaukos Corp Stock Faces Monthly Pressure Amid Analyst Optimism and Glaucoma Innovation Push - AD HOC NEWS

Mar 23, 2026
pulisher
Mar 23, 2026

Piper Sandler reiterates Glaukos stock rating on growth outlook - Investing.com UK

Mar 23, 2026
pulisher
Mar 23, 2026

Piper Sandler reiterates Glaukos stock rating on growth outlook By Investing.com - Investing.com Australia

Mar 23, 2026
pulisher
Mar 22, 2026

Why is Glaukos (GKOS) down 14.7% since last earnings report? - MSN

Mar 22, 2026
pulisher
Mar 21, 2026

JPMorgan Chase & Co. Has $54.65 Million Stock Position in Glaukos Corporation $GKOS - marketbeat.com

Mar 21, 2026
pulisher
Mar 20, 2026

Glaukos Introduces Epioxa, Accelerating Expansion in Corneal Therapy - Bitget

Mar 20, 2026
pulisher
Mar 20, 2026

Glaukos Announces Commercial Availability of Epioxa, a Transformative Innovation in Interventional Keratoconus Care - marketscreener.com

Mar 20, 2026
pulisher
Mar 20, 2026

Glaukos Corp. Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators - Markets Mojo

Mar 20, 2026
pulisher
Mar 20, 2026

Glaukos Launches Epioxa, Boosts Growth in Corneal Treatments - Yahoo Finance Singapore

Mar 20, 2026
pulisher
Mar 20, 2026

Glaukos (GKOS) Launches Epioxa HD for Keratoconus Treatment - GuruFocus

Mar 20, 2026
pulisher
Mar 20, 2026

Glaukos Corporation (NYSE:GKOS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 20, 2026
pulisher
Mar 20, 2026

Glaukos Announces Commercial Availability of Epioxa for Incision-Free Keratoconus Care - VisionMonday.com

Mar 20, 2026
pulisher
Mar 19, 2026

Glaukos SVP Thurman sells $61,968 in GKOS stock By Investing.com - Investing.com India

Mar 19, 2026
pulisher
Mar 19, 2026

Navratil, Glaukos corp officer, sells $101k in GKOS stock By Investing.com - Investing.com Australia

Mar 19, 2026
pulisher
Mar 19, 2026

Glaukos (NYSE:GKOS) CFO Alex Thurman Sells 625 Shares - MarketBeat

Mar 19, 2026
pulisher
Mar 19, 2026

Glaukos SVP Thurman sells $61,968 in GKOS stock - Investing.com

Mar 19, 2026
pulisher
Mar 19, 2026

Navratil, Glaukos corp officer, sells $101k in GKOS stock - Investing.com

Mar 19, 2026
pulisher
Mar 19, 2026

Glaukos (NYSE: GKOS) CDO reports 1,031-share sale and tax withholding - Stock Titan

Mar 19, 2026
pulisher
Mar 19, 2026

Glaukos (NYSE: GKOS) CFO sells 625 shares under 10b5-1 plan - Stock Titan

Mar 19, 2026
pulisher
Mar 19, 2026

GLAUKOS (NYSE: GKOS) COO reports tax-withholding of 1,189 vested shares - Stock Titan

Mar 19, 2026
pulisher
Mar 19, 2026

[Form 4] GLAUKOS Corp Insider Trading A... - Stock Titan

Mar 19, 2026
pulisher
Mar 19, 2026

Glaukos' Epioxa now commercially available in the US - Eyes On Eyecare

Mar 19, 2026
pulisher
Mar 19, 2026

Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care - BioSpace

Mar 19, 2026
pulisher
Mar 19, 2026

Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report? - Yahoo Finance

Mar 19, 2026
pulisher
Mar 19, 2026

Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional - pharmiweb.com

Mar 19, 2026
pulisher
Mar 19, 2026

Glaukos announces commercial availability of Epioxa for the treatment of keratoconus - Optometry Times

Mar 19, 2026
pulisher
Mar 19, 2026

Glaukos Corporation Announces Commercial Availability Of Epioxa HD / Epioxa For Keratoconus Treatment - marketscreener.com

Mar 19, 2026
pulisher
Mar 19, 2026

Glaukos Launches Epioxa for Keratoconus Treatment - marketscreener.com

Mar 19, 2026
pulisher
Mar 19, 2026

Glaukos announces commercial availability of Epioxa HD/Epioxa - TipRanks

Mar 19, 2026

Glaukos Corporation (GKOS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Glaukos Corporation (GKOS) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Thurman Alex R.
SVP & CHIEF FINANCIAL OFFICER
Mar 24 '26
Sale
105.24
1,521
160,070
46,498
ZBH ZBH
$90.42
price up icon 2.03%
STE STE
$221.13
price up icon 0.80%
$62.80
price up icon 1.45%
PHG PHG
$27.40
price up icon 3.28%
$71.18
price up icon 3.50%
EW EW
$80.08
price up icon 0.73%
大文字化:     |  ボリューム (24 時間):